Skip to content
GB

GLCFHARMAK BIOTECH LLP

Chennai, Tamil Nadu

DPIIT recognised District Healthcare & Lifesciences

In their own words

GlcfharmaK Biotech LLP is a small glycobiology based startup conducting innovative research in the development of novel therapeutics. Our primary focus is enabling post translational modification of proteins involved in glycosylation reactions for therapeutic interventions. Presently we are working on a novel diabetes drug candidate which has shown credible results on baseline assays conducted in comparison with type 2 diabetes drugs available in the market. We have a collaboration with BIG grant partner on an antibacterial formulation against gram negative bacteria causing Infectious diarrhoea. We won the Best Social Impact award project for startups in Bio startups 2019, selected for final 10 in Grand challenges India and were runners up in Eureka conducted by IIT Mumbai. There are 3 researchers working in the company with experience in Biochemistry, Molecular biology and Glycobiology.

Written by the company on its public Startup India profile. Not verified by us.

What the record says

DPIIT recognition number
DIPP200213
CIN
ACI-4169
Registered on Startup India
2025
Self-declared stage
EarlyTraction

NA

Where this is

District

Chennai

Tamil Nadu

Startup India records the district. We do not have a street address for this company, and we will not invent one.

No point is drawn, because we do not have one.

Geocode confidence: low

See all Chennai startups on the map

What we do not know

We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.

Is this your company?

Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, write to trust@indianstartupmap.com.

How we built this record